Peter Bradley
Vorstandsvorsitzender bei Clever Culture Systems AG
Profil
Peter Bradley is currently the Chief Executive Officer at Clever Culture Systems AG, and is also a member of AusBiotech Ltd.
and New Zealand Biotechnologies Ltd.
He previously worked as the Managing Director at Qatalyst Bioconsulting, Kode Biotech Ltd., and LBT Innovations Ltd.
He was also the Head of Product Development & Regulatory Affairs at CSL Ltd.
and the Chief Business Development Officer at Amplia Therapeutics Ltd.
Mr. Bradley has a graduate degree from Melbourne Business School and an undergraduate degree from the University of South Australia.
Aktive Positionen von Peter Bradley
| Unternehmen | Position | Beginn |
|---|---|---|
| New Zealand Biotechnologies Ltd. | Corporate Officer/Principal | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Corporate Officer/Principal | - |
Clever Culture Systems AG
 Clever Culture Systems AG Medical SpecialtiesHealth Technology Part of LBT Innovations Ltd., Clever Culture Systems AG is a Swiss company that specializes in automated plate assessment systems for microbiology labs. The company is based in Bach SZ, Switzerland and is led by experts with experience in medical science, drug and diagnostic product development, and the pathology industry. The company's flagship product, the APAS, combines artificial intelligence and digital imaging technology to deliver faster results for microbiologists. The CEO of the company is Peter Bradley. Clever Culture Systems was acquired by LBT Innovations Ltd. from Hettich Holding Beteiligungs- und Verwaltungs GmbH on December 31, 2021 for $7.88 million. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Peter Bradley
| Unternehmen | Position | Ende |
|---|---|---|
Kode Biotech Ltd.
 Kode Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Kode Biotech Ltd. is a New Zealander company that engages in biotechnology development. The private company is based in Auckland, New Zealand. | Corporate Officer/Principal | 01.12.2007 |
| CSL LIMITED | General Counsel | 01.01.1999 |
| AMPLIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Qatalyst Bioconsulting
 Qatalyst Bioconsulting Miscellaneous Commercial ServicesCommercial Services Qatalyst Bioconsulting provides consulting services for bio-marketing and commercialization. | Vorstandsvorsitzender | - |
| LBT INNOVATIONS LIMITED | Corporate Officer/Principal | - |
Ausbildung von Peter Bradley
| Melbourne Business School | Graduate Degree |
| University of South Australia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CSL LIMITED | Health Technology |
| LBT INNOVATIONS LIMITED | Health Technology |
| AMPLIA THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
| New Zealand Biotechnologies Ltd. | |
Clever Culture Systems AG
Clever Culture Systems AG Medical SpecialtiesHealth Technology Part of LBT Innovations Ltd., Clever Culture Systems AG is a Swiss company that specializes in automated plate assessment systems for microbiology labs. The company is based in Bach SZ, Switzerland and is led by experts with experience in medical science, drug and diagnostic product development, and the pathology industry. The company's flagship product, the APAS, combines artificial intelligence and digital imaging technology to deliver faster results for microbiologists. The CEO of the company is Peter Bradley. Clever Culture Systems was acquired by LBT Innovations Ltd. from Hettich Holding Beteiligungs- und Verwaltungs GmbH on December 31, 2021 for $7.88 million. | Health Technology |
Qatalyst Bioconsulting
Qatalyst Bioconsulting Miscellaneous Commercial ServicesCommercial Services Qatalyst Bioconsulting provides consulting services for bio-marketing and commercialization. | Commercial Services |
Kode Biotech Ltd.
Kode Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Kode Biotech Ltd. is a New Zealander company that engages in biotechnology development. The private company is based in Auckland, New Zealand. | Commercial Services |
